CIRM Eyeing Major Reliance on Industry Cash
The president of the California stem cell agency, Alan Trounson, says it is considering funding its future with money from the biotech industry.
The possibility of a state government agency relying on industry dollars raises significant and new conflict of interest questions concerning the $3 billion effort. CIRM's governing board is already filled with …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.